Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

sesamodil

Known as: 3,4-dihydro-2-(5-methoxy-2-(3-(N-methyl-N-(2-((3,4-methylenedioxy)phenoxy)ethyl)amino)propoxy)phenyl)-4-methyl-3-oxo-2H-1,4-benzothiazine, SEMOTIADIL 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
The peroxidation step in lipid transformation is considered to be essential in the pathogenesis of atherosclerosis. Calcium… Expand
1999
1999
CP-060S is a novel compound that can inhibit the slow inward calcium current as well as the veratridine-induced, noninactivating… Expand
1998
1998
To identify the binding domain of a new Ca2+ antagonist semotiadil on L-type Ca2+channels from skeletal muscle, photolabeling was… Expand
1997
1997
An on-line frontal analysis HPLC system was developed for the determination of the unbound concentrations of semotiadil, a new… Expand
1997
1997
The influence of semotiadil fumarate, a novel vasoselective Ca2+ channel antagonist with a benzothiazine skeleton, was measured… Expand
1996
1996
We compared the effects of semotiadil, a novel Ca2+ channel blocker, with those of diltiazem on survival and regression of right… Expand
1995
1995
1 The aim of the present study was to determine whether antianginal efficacy of semotiadil fumarate (SD‐3211), a structurally… Expand
1994
1994
A carbon-11 labeled benzothiazine calcium antagonist, (+)-(R)-2-[5-methoxy-2-[3-[methyl[2-[(3,4- methylenedioxy)phenoxy]ethyl… Expand
1994
1994
Summary: We assessed the binding characteristics of a benzothiazine Ca2+-channel antagonist, semotiadil, in canine skeletal… Expand
1992
1992
Summary: The present experiments were undertaken to elucidate Ca2+ antagonistic and binding properties of semotiadil and its (S… Expand